Ligand validation:5LGR

PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5LGR_PG6_B_502	7%	77%	0.193	0.649	0.51	0.4	-	-	0	0	100%	1
5LGQ_PG6_A_505	3%	76%	0.287	0.6	0.5	0.44	-	-	1	0	100%	1
5K8V_PG6_B_502	2%	79%	0.256	0.544	0.53	0.34	-	-	0	0	100%	1
3JR7_PG6_A_299	67%	21%	0.093	0.899	1.78	1.57	5	3	3	0	100%	1
5UL5_PG6_B_604	59%	73%	0.11	0.942	0.49	0.56	-	-	0	0	72%	0.7222
7YUG_PG6_A_401	55%	68%	0.149	0.918	0.41	0.8	-	1	1	0	100%	1
4F7F_PG6_A_202	49%	57%	0.118	0.875	0.59	1.04	-	1	0	0	94%	0.9444
7NB4_PG6_A_403	49%	95%	0.19	0.938	0.23	0.17	-	-	1	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.